| 1 | — (10.1186/1476-0711-5-26) | Abstract References ORCID License | 243.30 | 270 |
| 2 | — (10.1186/1476-0711-5-28) | Abstract References ORCID License | 238.20 | 240 |
| 3 | The role of acidification in the inhibition of Neisseria gon… (10.1186/1476-0711-10-8) | Abstract References ORCID License | 213.03 | 134 |
| 4 | Are we aware how contaminated our mobile phones with nosocom… (10.1186/1476-0711-8-7) | Abstract References ORCID License | 210.38 | 126 |
| 5 | Non-typhoidal Salmonella bacteraemia: Epidemiology, clinical… (10.1186/1476-0711-8-15) | Abstract References ORCID License | 209.34 | 123 |
| 6 | Isolation and identification of antimicrobial compound from… (10.1186/1476-0711-8-20) | Abstract References ORCID License | 206.45 | 115 |
| 7 | Trends in antibacterial resistance among Streptococcus pneum… (10.1186/1476-0711-7-1) | Abstract References ORCID License | 205.31 | 112 |
| 8 | Systematic review and meta-analysis of mortality of patients… (10.1186/s12941-017-0191-3) | Abstract ORCID License | 205.29 | 545 |
| 9 | New antibiotics for bad bugs: where are we? (10.1186/1476-0711-12-22) | Abstract ORCID License | 189.28 | 333 |
| 10 | Application of a high throughput Alamar blue biofilm suscept… (10.1186/1476-0711-8-28) | Abstract References ORCID License | 189.21 | 77 |
| 11 | Resistance integrons: class 1, 2 and 3 integrons (10.1186/s12941-015-0100-6) | Abstract ORCID License | 186.96 | 310 |
| 12 | Antimicrobial resistance in equine faecal Escherichia coli i… (10.1186/1476-0711-9-12) | Abstract References ORCID License | 186.33 | 72 |
| 13 | — (10.1186/1476-0711-5-23) | Abstract References ORCID License | 185.73 | 71 |
| 14 | Inhibitory effect of essential oils obtained from plants gro… (10.1186/1476-0711-8-8) | Abstract References ORCID License | 183.88 | 68 |
| 15 | — (10.1186/1476-0711-5-6) | Abstract References ORCID License | 180.62 | 63 |
| 16 | Predicting the sensitivity and specificity of published real… (10.1186/1476-0711-7-18) | Abstract References ORCID License | 172.43 | 52 |
| 17 | — (10.1186/1476-0711-5-30) | Abstract References ORCID License | 169.90 | 49 |
| 18 | Prevalence of Helicobacter pylori vacA, cagA, iceA and oipA… (10.1186/1476-0711-9-10) | Abstract References ORCID License | 169.90 | 49 |
| 19 | Antifungal activity of schinol and a new biphenyl compound i… (10.1186/1476-0711-9-30) | Abstract References ORCID License | 169.02 | 48 |
| 20 | Fecal carriage of extended-spectrum β-lactamases and AmpC-pr… (10.1186/1476-0711-13-22) | Abstract References ORCID License | 168.12 | 47 |
| 21 | Superhydrophilicity and antibacterial property of a Cu-dotte… (10.1186/1476-0711-9-25) | Abstract References ORCID License | 165.32 | 44 |
| 22 | Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infec… (10.1186/1476-0711-11-32) | Abstract ORCID License | 164.90 | 157 |
| 23 | Factors affecting antimicrobial activity of MUC7 12-mer, a h… (10.1186/1476-0711-6-14) | Abstract References ORCID License | 163.35 | 42 |
| 24 | Comprehensive bactericidal activity of an ethanol-based hand… (10.1186/1476-0711-7-2) | Abstract References ORCID License | 163.35 | 42 |
| 25 | Empiric antibiotic therapy in acute uncomplicated urinary tr… (10.1186/1476-0711-8-27) | Abstract References ORCID License | 163.35 | 42 |
| 26 | — (10.1186/1476-0711-5-10) | Abstract References ORCID License | 162.32 | 41 |
| 27 | Primary resistance to clarithromycin, metronidazole and amox… (10.1186/1476-0711-9-22) | Abstract References ORCID License | 162.32 | 41 |
| 28 | — (10.1186/1476-0711-5-25) | Abstract References ORCID License | 160.21 | 39 |
| 29 | Infected foot ulcers in male and female diabetic patients: a… (10.1186/1476-0711-9-2) | Abstract References ORCID License | 160.21 | 39 |
| 30 | Uropathogenic Escherichia coli in Iran: Serogroup distributi… (10.1186/1476-0711-12-8) | Abstract ORCID License | 159.29 | 132 |
| 31 | Efficacy and safety profile of linezolid in the treatment of… (10.1186/s12941-016-0156-y) | Abstract ORCID License | 159.04 | 131 |
| 32 | Antibacterial activity of statins: a comparative study of At… (10.1186/1476-0711-11-13) | Abstract ORCID License | 158.29 | 128 |
| 33 | Infections caused by mycobacterium tuberculosis in patients… (10.1186/1476-0711-6-16) | Abstract References ORCID License | 157.98 | 37 |
| 34 | Antibacterial activity against β- lactamase producing Methic… (10.1186/1476-0711-11-18) | Abstract ORCID License | 156.74 | 122 |
| 35 | Central venous catheter infection with Bacillus pumilus in a… (10.1186/1476-0711-6-12) | Abstract References ORCID License | 155.63 | 35 |
| 36 | Antifungal treatment for invasive Candida infections: a mixe… (10.1186/1476-0711-8-23) | Abstract References ORCID License | 155.63 | 35 |
| 37 | Aetiological agents of cerebrospinal meningitis: a retrospec… (10.1186/1476-0711-11-28) | Abstract References ORCID License | 154.41 | 34 |
| 38 | Pitfalls in efficacy testing – how important is the validati… (10.1186/1476-0711-7-20) | Abstract References ORCID License | 154.41 | 34 |
| 39 | Comparison of Clinical Laboratory Standards Institute and Eu… (10.1186/s12941-016-0135-3) | Abstract ORCID License | 153.40 | 110 |
| 40 | Chemical structure and pharmacokinetics of novel quinolone a… (10.1186/s12941-016-0150-4) | Abstract ORCID License | 152.51 | 107 |
| 41 | Prevalence and antimicrobial susceptibilities of bacteria is… (10.1186/1476-0711-3-7) | Abstract ORCID License | 152.20 | 106 |
| 42 | Pandemics, pathogenicity and changing molecular epidemiology… (10.1186/s12941-017-0185-1) | Abstract ORCID License | 152.20 | 106 |
| 43 | Strongyloides stercoralis hyperinfection in a patient with r… (10.1186/1476-0711-9-27) | Abstract References ORCID License | 150.51 | 31 |
| 44 | Antimicrobial susceptibility pattern of bacterial isolates f… (10.1186/1476-0711-13-14) | Abstract ORCID License | 149.67 | 98 |
| 45 | — (10.1186/1476-0711-5-8) | Abstract References ORCID License | 149.14 | 30 |
| 46 | Enteric alpha defensins in norm and pathology (10.1186/1476-0711-11-1) | Abstract References ORCID License | 147.71 | 29 |
| 47 | Diagnostic testing for Legionnaires’ disease (10.1186/s12941-017-0229-6) | Abstract ORCID License | 147.64 | 92 |
| 48 | ChikDenMaZika Syndrome: the challenge of diagnosing arbovira… (10.1186/s12941-016-0157-x) | Abstract ORCID License | 146.20 | 88 |
| 49 | Clinical characteristics and antimicrobial susceptibility of… (10.1186/s12941-015-0104-2) | Abstract ORCID License | 145.09 | 85 |
| 50 | An evaluation of E. coli in urinary tract infection in emerg… (10.1186/s12941-018-0255-z) | Abstract ORCID License | 145.09 | 85 |